Eiján AM - Search Results

1

Nitric oxide synthase, arginase and cyclooxygenase are involved in muscarinic receptor activation in different murine mammary adenocarcinoma cell lines.

Español A, Eiján AM, Mazzoni E, Davel L, Jasnis MA, Sacerdote De Lustig E, Sales ME. Español A, et al. Among authors: eijan am. Int J Mol Med. 2002 Jun;9(6):651-7. Int J Mol Med. 2002. PMID: 12011984

2

Modulation of tumor-induced angiogenesis by proteins of extracellular matrix.

Eiján AM, Davel L, Oisgold-Dagá S, de Lustig ES. Eiján AM, et al. Mol Biother. 1991 Mar;3(1):38-40. Mol Biother. 1991. PMID: 1712599

3

Angiogenic activity by spleen cell supernatants from tumor-bearing and tumor-resected mice.

Davel L, Miguez M, Jasnis MA, Eiján AM, Oisgold-Dagá S, Sacerdote de Lustig E. Davel L, et al. Among authors: eijan am. J Surg Oncol. 1988 Jan;37(1):44-8. doi: 10.1002/jso.2930370113. J Surg Oncol. 1988. PMID: 2447442

4

[Immunoregulation of tumor growth in a murine model].

de Bonaparte YP, Colombo L, Davel L, Diament M, Eiján AM, Jasnis MA, Klein S, de Kohan SS, Oisgold-Daga S, Stillitani I, et al. de Bonaparte YP, et al. Among authors: eijan am. Medicina (B Aires). 1989;49(3):265-70. Medicina (B Aires). 1989. PMID: 2487420 Spanish.

5

Isolated soluble fractions from spleen cell culture supernatants induce tumor enhancement.

Eiján AM, Jasnis MA, Motta AB, Oisgold-Dagá S. Eiján AM, et al. J Surg Oncol. 1989 Jun;41(2):134-8. doi: 10.1002/jso.2930410215. J Surg Oncol. 1989. PMID: 2724981

6

Nature of the spleen cell populations capable of releasing tumor enhancing factor.

Eiján AM, Jasnis MA, Kohan SS, Oisgold-Dagá S. Eiján AM, et al. J Surg Oncol. 1987 Nov;36(3):161-5. doi: 10.1002/jso.2930360303. J Surg Oncol. 1987. PMID: 3500369

7

[Modulation of angiogenesis induced by lymphocytes by extracellular matrix proteins].

Eiján AM, Davel L, de Lustig ES. Eiján AM, et al. Acta Physiol Pharmacol Ther Latinoam. 1993;43(3-4):53-7. Acta Physiol Pharmacol Ther Latinoam. 1993. PMID: 7540077 Spanish.

8

Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition.

Esteban Bertolesi G, Lauría de Cidre L, Sacerdote de Lustig E, Eiján AM. Esteban Bertolesi G, et al. Among authors: eijan am. Cancer Lett. 1995 Apr 14;90(2):123-31. doi: 10.1016/0304-3835(95)03693-q. Cancer Lett. 1995. PMID: 7736447

9

Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins.

Bertolesi GE, Lauría de Cidre L, Eiján AM. Bertolesi GE, et al. Among authors: eijan am. Tumour Biol. 1994;15(5):275-83. doi: 10.1159/000217902. Tumour Biol. 1994. PMID: 7991988

10

Effect of host-organ environment on the in vivo and in vitro behavior of a murine mammary adenocarcinoma.

Puricelli L, Gómez DE, Vidal MC, Eiján AM, Spinelli O, Alonso DF, de Lustig ES, Bal de Kier Joffé E. Puricelli L, et al. Among authors: eijan am. Tumour Biol. 1994;15(5):284-93. doi: 10.1159/000217903. Tumour Biol. 1994. PMID: 7991989

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters